Adherex Technologies Inc (ADH) Stock Quote

Detailed Quote for Adherex Technologies Inc (ADH)

close 52 Week Information

52 Week High

December 18, 2008

Close: 0.0697

52 Week Low

January 27, 2009

Close: 0.02

Today

Last Price
N/A

Change $
N/A

Change %
N/A

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
N/A

High
N/A

Low
N/A

Prev Close
N/A

Last Trade
N/A

Volume
0

52 Wk Hi
0.0697

52 Wk Low
0.02

Market Cap
N/A

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
25,157,861

EPS (TTM)
N/A

PE Ratio
N/A

close Exchange Information Listed On NYSE Amex Equities Exchange (AMX) Exchange
AMX

News and Media for Adherex Technologies Inc (ADH)

Sector News | Topic News

News for ADH

Mon, Mar 30, 2009

7:52 AM

Adherex Reports 2008 Fiscal Results - Marketwire Canada

Fri, Jan 09, 2009

8:01 AM

Adherex Files to Delist From the AMEX - Marketwire Canada

Wed, Dec 10, 2008

5:04 PM

Adherex Receives AMEX Delisting Notice-Implements Success-Based Incentive Program - Marketwire Canada

Wed, Nov 12, 2008

8:38 AM

Adherex Reports Third Quarter 2008 Financial Results - Marketwire Canada

Wed, Oct 29, 2008

8:31 AM

Adherex to Present at Windhover's Therapeutic Area Partnerships Meeting - Marketwire Canada

Wed, Aug 13, 2008

8:31 AM

Adherex Reports Second Quarter 2008 Financial Results - Marketwire Canada

Mon, Jun 02, 2008

8:32 AM

Adherex Announces Updated ADH-1 Chemotherapy Combination Data in Melanoma - Marketwire Canada

Mon, May 19, 2008

8:32 AM

Adherex Announces ASCO Abstract of ADH-1 in Melanoma - Marketwire Canada

Thu, May 15, 2008

8:31 AM

Adherex Announces Publication of ADH-1 Study in Cancer Research - Marketwire Canada

Wed, May 14, 2008

8:31 AM

Adherex Announces Agreement for STS Phase III Data - Marketwire Canada

Tue, May 13, 2008

9:02 AM

Adherex Reports First Quarter 2008 Financial Results - Marketwire Canada

Fri, Mar 28, 2008

8:31 AM

Adherex Reports 2007 Fiscal Results - Marketwire Canada

Wed, Mar 26, 2008

6:31 AM

Adherex Announces Phase III Trial With STS in Collaboration With the Children's Oncology Group - Marketwire Canada

Thu, Mar 20, 2008

8:31 AM

Adherex to Present ADH-1 Phase I/II Melanoma Trial Data at the 2008 Annual Meeting of the American Society Of Clinical Oncology (ASCO) - Marketwire Canada

Fri, Feb 22, 2008

8:31 AM

Adherex Receives Orphan Drug Designation for ADH-1 in Melanoma - Marketwire Canada

Thu, Jan 17, 2008

4:41 PM

Adherex Announces Phase IIb Expansion of ADH-1 Combination Study in Melanoma - Marketwire Canada

Wed, Nov 07, 2007

8:02 AM

Adherex Reports Third Quarter 2007 Financial Results - Marketwire Canada

Tue, Oct 30, 2007

7:37 AM

Adherex and the International Childhood Liver Tumour Strategy Group (SIOPEL) Announce the Launch of a Phase III Trial of STS - Marketwire Canada

Tue, Oct 23, 2007

8:31 AM

Adherex to Participate in Windhover's Therapeutic Area Partnerships Meeting - Marketwire Canada

Thu, Aug 09, 2007

8:41 AM

Adherex Reports Second Quarter 2007 Financial Results - Marketwire Canada

More News for ADH >>

Tags for Adherex Technologies Inc

Research stocks or mutual funds related to Adherex Technologies Inc by keywords or tags. Find companies that have a similar focus to ADH. The keywords below have been associated to ADH by either user submission or electronic means.

pharmaceutical articles advanced therapy clinical trial enrollment clinical trials liability clinical research trial human cell lines biotech news pharmaceutical publication biotechnology news financial companies pharmaceutical market pharmaceutical investment apoptosis assays niche pharmaceutical pharmaceutical study investment products clinical pharmacology pharmaceutical research and development financial statements medical label financial investments clinical trial process Biological Products normal cell pharmaceutical medical packaging pharmaceutical tank pharmaceutical software apoptosis detection cell line development phase iii clinical trials warrick pharmaceutical pharmaceutical executives clinical research licensed products pharmaceutical cro diabetic product biotechnology training pharmaceutical sales financial technology clinical trials industry financial headlines paid clinical trial phase 3 clinical trials clinical trials manager financial objectives pharmaceutical development clinical trial protocol calculators financial financial factoring cell lines